Portfolio Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Portfolio Strategies’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-90	Closed	-$6K	–	55
2018 Q3	$6K	Hold	90	–	–	﹤0.01%	167
2018 Q2	$5K	Sell	90 -1,000	-92%	-$54K	﹤0.01%	192
2018 Q1	$69K	Hold	1,090	–	–	0.05%	61
2017 Q4	$67K	Buy	+1,090	New	+$68.2K	0.05%	70

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Portfolio Strategies's BMY Position: Q4 2018 in Review

Portfolio Strategies sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 90 shares — an estimated $6K sold.

Portfolio Strategies first reported a position in BMY in Q4 2017 and held it in 4 quarters. The position peaked at $69K in Q1 2018. 1,765 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

Portfolio Strategies reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
Portfolio Strategies sold 90 Bristol-Myers Squibb shares in Q4 2018, an estimated $6K.
Portfolio Strategies first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 4 quarters.
Portfolio Strategies's Bristol-Myers Squibb position peaked at $69K in Q1 2018.
1,765 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on Portfolio Strategies's 13F filing for Q4 2018, filed 4 Feb 2019.